{"RichTextAreas":[{"Title":"","Overview":"","OverviewExpanded":"

Sidley Austin is proud to sponsor the 2013 New Paradigms Conference, featuring key individuals from biotech, pharma and the investment community to advance R&D through alternative sources of funding, non-traditional partnering strategies and regulatory insights. Coleen Klasmeier, a partner and Global Coordinator in Sidley’s Food, Drug & Medical Device Regulatory Practice in Washington, D.C., will participate in a panel discussion, “A Disruptive Approach to Fundamental Reform.”

Panel Discussion
“A Disruptive Approach to Fundamental Reform”
January 8, 2013, 3:45 pm

Moderated by: Peter Milner, MD, CEO, Heart Metabolics and Co-Founder, CVT, ARYx, Armetheon and Optivia

Changing approval standards \n
Addressing the misconception of reform and the effect on the FDA \n
Are we taking the right approach in amending the statute every five years?

Panelists:

David Gollaher, PhD, President & CEO, California Healthcare Institute

Coleen Klasmeier, Global Coordinator, Food, Drug & Medical Device Regulatory Practice, Sidley Austin LLP

Chris Meda , Vice Chair, Women in Bio (WIB) San Francisco Chapter

","OverviewReadMoreLabel":"More","OverviewViewLessLabel":"Less"}],"CssClass":"","FolderTemplateID":null,"SiteImproveReadMoreDataAttributes":""}